Evogene Ltd. - ROE
EVGN.TA
Price:
$162
Market Cap:
$4.63M
Evogene Ltd. is a computational biology firm specializing in the identification and advancement of products across human health and agricultural sectors. Its proprietary Computational Predictive Biology (CPB) platform leverages deep biological insights, big data, and artificial intelligence to precisely uncover and guide the creation of life science solutions, including novel microbes, small molecules, and genetic components. The company operates through distinct divisions: Agriculture, Human Health, and Industrial Applications. The Agriculture division concentrates on improving crop performance through the development of advanced seed traits, agricultural chemicals, and biological products ...[Read more]
Industry
Biotechnology
IPO Date
2007-06-13
Stock Exchange
TLV
Ticker
EVGN.TA
PE Ratio
[-0.37]
ROE
[937.72%]
Current Ratio
[2.77]
Dividend Yield
[0%]
Enterprise Value
[-1930895.93]
Dividend History
The ROE as of July 2026 (TTM) for Evogene Ltd. (EVGN.TA) is 937.72%
According to Evogene Ltd.’s latest financial reports and current stock price. The company's current ROE is 937.72%. This represents a change of -47.70% compared to the average of 1.79% of the last 4 quarters.
Evogene Ltd. (EVGN.TA) Historical ROE (quarterly & annually)
How has EVGN.TA ROE performed in the past?
The mean historical ROE of Evogene Ltd. over the last ten years is 1.09%. The current 937.72% ROE has changed -14.23% with respect to the historical average. Over the past ten years (40 quarters), EVGN.TA's ROE was at its highest in in the December 2025 quarter at 6.47%. The ROE was at its lowest in in the June 2024 quarter at -176.69%.
Average
1.09%
Median
-39.80%
Minimum
-198.12%
Maximum
10.35%
Evogene Ltd. (EVGN.TA) ROE by Quarter and Year
Discovering the peaks and valleys of Evogene Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 810.79%
Maximum Annual ROE = 10.35%
Minimum Annual Increase = -673.46%
Minimum Annual ROE = -198.12%
| Year | ROE | Change |
|---|---|---|
| 2025 | 10.35% | 810.79% |
| 2024 | 1.14% | -673.46% |
| 2023 | -198.12% | 85.41% |
| 2022 | -106.85% | 89.63% |
| 2021 | -56.35% | -1.00% |
| 2020 | -56.91% | 49.30% |
| 2019 | -38.12% | -8.08% |
| 2018 | -41.47% | 38.08% |
| 2017 | -30.04% | 33.82% |
| 2016 | -22.44% | 35.29% |
Evogene Ltd. (EVGN.TA) Average ROE
How has EVGN.TA ROE performed in the past?
The current ROE of Evogene Ltd. (EVGN.TA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.76%
5-year avg
2.22%
10-year avg
1.09%
Evogene Ltd. (EVGN.TA) ROE vs. Peers
How is EVGN.TA’s ROE compared to its peers?
Evogene Ltd.’s ROE is greater than XTL Biopharmaceuticals Ltd. (-269.02%), greater than BioLineRx Ltd. (-47.86%), greater than Can-Fite BioPharma Ltd. (-201.06%), greater than Clal Biotechnology Industries Ltd. (-60.47%), less than Tikun Olam-Cannbit Pharmaceuticals Ltd. (126.88%), greater than BioLight Life Sciences Ltd. (-42.66%), greater than Identi Healthcare Ltd. (-76.09%), greater than Allmed Solutions Ltd (-49.08%), greater than PlantArc Bio Ltd. (-23.90%), greater than Purple Biotech Ltd. (-123.47%),
| Company | ROE | Market cap |
|---|---|---|
| -269.02% | $18.92M | |
| -47.86% | $39.16M | |
| -201.06% | $25.30B | |
| -60.47% | $42.35M | |
| 126.88% | $3.23M | |
| -42.66% | $21.42M | |
| -76.09% | $23.76M | |
| -49.08% | $31.33M | |
| -23.90% | $7.32M | |
| -123.47% | $5.38M |
Build a custom stock screener for Evogene Ltd. (EVGN.TA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evogene Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Evogene Ltd. (EVGN.TA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Evogene Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Evogene Ltd.'s ROE?
How is the ROE calculated for Evogene Ltd. (EVGN.TA)?
What is the highest ROE for Evogene Ltd. (EVGN.TA)?
What is the 3-year average ROE for Evogene Ltd. (EVGN.TA)?
What is the 5-year average ROE for Evogene Ltd. (EVGN.TA)?
How does the current ROE for Evogene Ltd. (EVGN.TA) compare to its historical average?